Back to News
Market Impact: 0.56
Telix to Buy Isotope Maker ITM in Deal Worth Up to $2.35 Billion
Source: Bloomberg
M&A & RestructuringHealthcare & BiotechCompany Fundamentals
Telix Pharmaceuticals agreed to acquire ITM Isotope Technologies Munich for up to $2.35 billion. The transaction secures a key supply source of radioactive materials used in cancer therapies and adds a late-stage drug candidate, strengthening Telix's radiopharmaceutical pipeline and vertical integration.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.62
Ticker Sentiment
TLX0.72
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Snap shares fall over 10% on third-quarter earnings miss
- China Blocks SoftBank Acquisition of ABB Robot Unit, FT Says
- Leonardo raises 2026 order guidance after strong 9-mth performance
- HelloFresh Q3 core profit tops forecasts as marketing cuts hit orders
- Microsoft declines Nscale Texas expansion ahead of $35 bln IPO - report